![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Significant Efficacy and Long-term Safety Difference With TAF-Based STR in Naïve Adults
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
Jose Arribas,1 Melanie Thompson,2 Paul Sax,3 Bernhard Haas,4 Cheryl McDonald,5 David Wohl,6 Edwin DeJesus,7 Amanda Clarke,8 Moupali Das,9 Scott McCallister9
1Hospital Universitario La Paz, Madrid, Spain; 2AIDS Research Consortium of Atlanta, GA; 3Brigham and Women’s Hospital, Boston, MA; 4LKH Graz Süd-West, Graz, Austria; 5Tarrant County Infectious Disease Associates, Fort Worth, TX;
6University of North Carolina at Chapel Hill School of Medicine; 7Orlando Immunology Center, Orlando, FL; 8Brighton & Sussex University Hospitals NHS Trust, Brighton, UK; 9Gilead Sciences, Inc., Foster City, CA
![0215171](../images/021517/021517-16/0215171.gif)
![0215172](../images/021517/021517-16/0215172.gif)
![0215173](../images/021517/021517-16/0215173.gif)
![0215174](../images/021517/021517-16/0215174.gif)
![0215175](../images/021517/021517-16/0215175.gif)
![0215176](../images/021517/021517-16/0215176.gif)
![0215177](../images/021517/021517-16/0215177.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|